Where they practice, who they consult.
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
- 25+ years in lymphoma
- English, Mandarin
What they personally lead.
Training and recognition
Senior-author publications in Cancer Cell, Blood, and Journal of Clinical Oncology on molecular subtyping of DLBCL and on combination targeted therapy in relapsed/refractory lymphoma; principal investigator on Chinese cooperative lymphoma trials; key opinion leader in CSCO lymphoma guideline drafting
What to expect
A strong choice for patients with relapsed/refractory diffuse large B-cell lymphoma or T-cell lymphoma seeking access to novel-agent or CAR-T trials, with molecular profiling available to guide therapy.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Zhao Weili's background to other specialists in Shanghai. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.